Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis
Archives of Iranian Medicine · 2026
DOI: 10.34172/aim.34922 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Archives of Iranian Medicine, 2026. Verfasst von Fardad Ejtehadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Cholangitis, Sclerosing, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cholangiocarcinoma (CCA) is the most common malignancy in patients with primary sclerosing cholangitis (PSC). It is typically associated with low survival rates due to late diagnosis. This study aimed to evaluate the predictors of incidental CCA in PSC patients.
Methods
In this cross-sectional study, we included 425 patients aged 18 years or older who underwent liver transplant with a confirmed diagnosis of PSC. Demographic data, pre-transplant clinical features, and para-clinical evidence were obtained from medical records. Pathology experts examined livers removed during transplantation, and CCA was diagnosed accordingly. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were conducted to assess the risk factors for incidental CCA and the effectiveness of carbohydrate antigen 19-9 (CA 19‒9) in predicting CCA, respectively.
Results
Of the 425 included patients, 29 had PSC-CCA and 396 patients had PSC alone. According to the multivariable logistic model, CA 19‒9 (odds ratio [OR]=1.001, 95% confidence interval [CI]: 1.000‒1.001, P-value=0.041) and weight loss (OR=4.712, 95% CI: 1.392 to 15.947, P-value=0.013) were significantly associated with CCA development. ROC curve analysis also revealed that CA 19‒9 could predict CCA (AUC=0.737; 95% CI: 0.689‒0.782) at an optimal cut-off point above 46 U/mL, with a good sensitivity (68%, bootstrapped 95% CI: 62‒74%) and specificity (72.32%, bootstrapped 95% CI: 68‒76%).
Conclusion
We found that CA 19‒9 and weight loss are independent predictors of incidental CCA in PSC patients, and a CA 19‒9 level above 46 U/mL has relatively good predictive power for incidental CCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Internal Medicine Department, Shiraz University of Medical Sciences, Shiraz, Iran.
- Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Fardad Ejtehadi, Ali Reza Safarpour, Sara Shojaei-Zarghani, Salar Azadnik
Zitieren
APA
Ejtehadi, F., Hashemieh, S., Safarpour, A. R., Shojaei-Zarghani, S., Azadnik, S., Shamsaeefar, A., & Rahimikashkooli, N. (2026). Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis. Archives of Iranian Medicine. https://doi.org/10.34172/aim.34922
Vancouver
Ejtehadi F, Hashemieh S, Safarpour AR, Shojaei-Zarghani S, Azadnik S, Shamsaeefar A, et al. Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis. Archives of Iranian Medicine. 2026. doi:10.34172/aim.34922
BibTeX
@article{Ejtehadi2026,
author = {Ejtehadi, Fardad and Hashemieh, Saeid and Safarpour, Ali Reza and Shojaei-Zarghani, Sara and Azadnik, Salar and Shamsaeefar, Alireza and Rahimikashkooli, Nima},
title = {Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis},
journal = {Archives of Iranian Medicine},
year = {2026},
doi = {10.34172/aim.34922}
}
EUVIMED